Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
Conclusion: Our results suggested that both gut microbiota alteration and adiponectin variability may be drivers of NAFLD progression and that targeting the gut microbiota, such as via administration of a probiotic, may delay NAFLD progression via adiponectin.Cell Physiol Biochem 2018;51:2123 –2135
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Alcoholism | Bacteroides Infection | Biochemistry | Cytology | Diets | Fatty Liver Disease (FLD) | Genetics | High Fat | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Pathology | Physiology | Probiotics | Statistics | Study | Urology & Nephrology